Skip to main content
Eric Lander, MD, Oncology, Nashville, TN, Tennessee Valley HCS - Nashville and Murfreesboro

EricMichaelLanderMD(He/Him)

Oncology Nashville, TN

Hematologic Oncology

Clinical Fellow Hematology/Oncology - Vanderbilt University Medical Center

Dr. Lander is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lander's full profile

Already have an account?

  • Office

    1161 21st Avenue South # D-3100 Medical Center Nor
    Nashville, TN 37232
    Phone+1 615-322-3384
    Fax+1 615-343-4466
  • Is this information wrong?

Summary

  • Dr. Eric Lander is an oncologist in Nashville, TN and is affiliated with multiple hospitals in the area, including Nashville General Hospital, Tennessee Valley Healthcare System, and Tennessee Valley Healthcare System. He received his medical degree from University of Arizona College of Medicine-Tucson and has been in practice 4 years. He specializes in hematologic oncology. He has numerous publications in peer-reviewed journals and experience in clinical trial design.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Hematology and Medical Oncology, 2021 - 2024
  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Internal Medicine, 2018 - 2021
  • University of Arizona College of Medicine
    University of Arizona College of MedicineClass of 2018

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 2022 - 2026
  • MN State Medical License
    MN State Medical License 2024 - 2025
  • American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

Press Mentions

  • Natera Announces New Signatera™ MRD Data at 2023 AACR Annual Meeting
    Natera Announces New Signatera™ MRD Data at 2023 AACR Annual MeetingApril 14th, 2023
  • New Signateratm MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023
    New Signateratm MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023January 19th, 2023
  • New Signatera™ MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023
    New Signatera™ MRD Data in Gastrointestinal Cancers to Be Presented at the ASCO GI Symposium 2023January 19th, 2023
  • Join now to see all

Hospital Affiliations